Erythropoiesis-stimulating agent
Medicine that stimulates red blood cell production / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Erythropoiesis-stimulating agent?
Summarize this article for a 10 year old
Erythropoiesis-stimulating agents (ESA) are medications which stimulate the bone marrow to make red blood cells.[3] They are used to treat anemia due to end stage kidney disease, chemotherapy, major surgery, or certain treatments in HIV/AIDS.[3][2] In these situations they decrease the need for blood transfusions.[2] The different agents are more or less equivalent.[2] They are given by injection.[2]
Erythropoiesis-stimulating agent | |
---|---|
Drug class | |
Class identifiers | |
Synonyms | Erythropoiesis-stimulating drugs,[1] erythropoietin-type blood factors[2] |
Use | Anemia due to end stage kidney disease, chemotherapy, major surgery, or certain treatments in HIV/AIDS[3][2] |
ATC code | B03XA |
Legal status | |
In Wikidata |
Common side effects may include joint pain, rash, vomiting, and headache.[4] Serious side effects may include heart attacks, stroke, increased cancer growth, or pure red cell aplasia.[2] It is unclear if use is safe during pregnancy.[5][6] They work similar to naturally occurring erythropoietin.[3]
They were first approved for medical use in the United States in 1989.[5] It is on the World Health Organization's List of Essential Medicines.[7] Commercially available agents include epoetin alfa and darbepoetin alfa, and biosimilars.[3][2] Use among athletes is prohibited by the World Anti-Doping Agency.[5]